$3.81
0.52% yesterday
Nasdaq, Oct 01, 10:00 pm CET
ISIN
US7599101026
Symbol
KRMD

Repro-Med Systems, Inc. Stock price

$3.81
-0.41 9.72% 1M
+1.30 51.79% 6M
-0.04 1.04% YTD
+1.11 41.11% 1Y
+1.54 67.84% 3Y
-3.30 46.41% 5Y
+3.42 864.56% 10Y
+3.60 1,714.29% 20Y
Nasdaq, Closing price Wed, Oct 01 2025
-0.02 0.52%

Key metrics

Basic
Market capitalization
$177.1m
Enterprise Value
$169.3m
Net debt
positive
Cash
$8.1m
Shares outstanding
46.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
4.8 | 4.3
EV/Sales
4.6 | 4.2
EV/FCF
negative
P/B
10.7
Financial Health
Equity Ratio
61.8%
Return on Equity
-36.1%
ROCE
-24.9%
ROIC
-30.0%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$36.9m | $40.7m
EBITDA
$-4.1m | $-306.0k
EBIT
$-4.9m | $-4.3m
Net Income
$-4.5m | $-3.8m
Free Cash Flow
$-2.2m
Growth (TTM | estimate)
Revenue
19.6% | 21.1%
EBITDA
35.2% | 94.5%
EBIT
32.1% | 34.0%
Net Income
61.6% | 37.9%
Free Cash Flow
-98.2%
Margin (TTM | estimate)
Gross
63.2%
EBITDA
-11.0% | -0.8%
EBIT
-13.2%
Net
-12.3% | -9.3%
Free Cash Flow
-6.0%
More
EPS
$-0.1
FCF per Share
$0.0
Short interest
3.5%
Employees
80
Rev per Employee
$420.0k
Show more

Is Repro-Med Systems, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,001 stocks worldwide.

Repro-Med Systems, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Repro-Med Systems, Inc. forecast:

9x Buy
82%
2x Hold
18%

Analyst Opinions

11 Analysts have issued a Repro-Med Systems, Inc. forecast:

Buy
82%
Hold
18%

Financial data from Repro-Med Systems, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
37 37
20% 20%
100%
- Direct Costs 14 14
17% 17%
37%
23 23
21% 21%
63%
- Selling and Administrative Expenses 22 22
10% 10%
61%
- Research and Development Expense 4.96 4.96
4% 4%
13%
-4.05 -4.05
35% 35%
-11%
- Depreciation and Amortization 0.80 0.80
10% 10%
2%
EBIT (Operating Income) EBIT -4.85 -4.85
32% 32%
-13%
Net Profit -4.52 -4.52
62% 62%
-12%

In millions USD.

Don't miss a Thing! We will send you all news about Repro-Med Systems, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Repro-Med Systems, Inc. Stock News

Neutral
Business Wire
14 days ago
DENVER & MAHWAH, N.J.--(BUSINESS WIRE)--ForCast Orthopedics, Inc. and KORU Medical Systems, Inc. (NASDAQ: KRMD) today jointly announced an agreement leveraging KORU Medical's FreedomEDGE® infusion system as part of ForCast's technology platform for the treatment of periprosthetic joint infection (PJI). PJI is a rare but serious complication of joint replacement procedures, and is challenging to...
Neutral
GlobeNewsWire
about one month ago
BROOKLYN PARK, Minn., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cirtec Medical, a leading strategic outsourcing partner for complex minimally invasive, active implantable devices and precision components, is pleased to announce the appointment of Shar Matin as Chief Executive Officer, effective September 2, 2025.
Neutral
Seeking Alpha
about 2 months ago
KORU Medical Systems, Inc. (NASDAQ:KRMD ) Q2 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants Linda M. Tharby - President, CEO & Director Thomas Adams - CFO, Secretary & Treasurer Conference Call Participants Anderson Schock - B.
More Repro-Med Systems, Inc. News

Company Profile

Repro-Med Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. Its product portfolio includes FREEDOM60, FreedomEdge syringe drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets. The company was founded by Andrew I. Sealfon and Adrian W. Zorgniotti on March 24, 1980 and is headquartered in Chester, NY.

Head office United States
CEO Linda Tharby
Employees 80
Founded 1980
Website www.korumedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today